Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2411116rdf:typepubmed:Citationlld:pubmed
pubmed-article:2411116lifeskim:mentionsumls-concept:C1514521lld:lifeskim
pubmed-article:2411116lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:2411116lifeskim:mentionsumls-concept:C0026651lld:lifeskim
pubmed-article:2411116lifeskim:mentionsumls-concept:C0037473lld:lifeskim
pubmed-article:2411116lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:2411116pubmed:issue3lld:pubmed
pubmed-article:2411116pubmed:dateCreated1985-9-6lld:pubmed
pubmed-article:2411116pubmed:abstractTextThe concentration of latamoxef sodium (LMOX) in serum and prostatic tissue was evaluated. Thirty seven patients with benign prostatic hypertrophy were given 1 g LMOX intravenously prior to prostatectomy. Prostatic tissue and blood were sampled at 1, 2 or 3 hrs after administration of LMOX. The concentration of LMOX in prostatic tissue was 17.4 +/- 3.4 micrograms/g tissue, 11.1 +/- 1.3 microgram/g tissue and 8.9 +/- 1.3 microgram/g tissue 1, 2 and 3 hrs after injection, respectively (mean +/- S.E.). The penetration ratio of LMOX (concentration in tissue/in serum) to prostate was 30-45%. Therefore, the 80% MIC of LMOX is lower than 8 micrograms/ml for most gram negative bacteria, the results suggest that LMOX is very effective against prostatitis caused by these organisms.lld:pubmed
pubmed-article:2411116pubmed:languagejpnlld:pubmed
pubmed-article:2411116pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2411116pubmed:citationSubsetIMlld:pubmed
pubmed-article:2411116pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2411116pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2411116pubmed:statusMEDLINElld:pubmed
pubmed-article:2411116pubmed:monthMarlld:pubmed
pubmed-article:2411116pubmed:issn0018-1994lld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:NakamuraHHlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:HayakawaMMlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:MatsuzakiSSlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:FujiokaTTlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:NagakuraKKlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:HataMMlld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:BaEElld:pubmed
pubmed-article:2411116pubmed:authorpubmed-author:TakacAAlld:pubmed
pubmed-article:2411116pubmed:issnTypePrintlld:pubmed
pubmed-article:2411116pubmed:volume31lld:pubmed
pubmed-article:2411116pubmed:ownerNLMlld:pubmed
pubmed-article:2411116pubmed:authorsCompleteYlld:pubmed
pubmed-article:2411116pubmed:pagination539-43lld:pubmed
pubmed-article:2411116pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:meshHeadingpubmed-meshheading:2411116-...lld:pubmed
pubmed-article:2411116pubmed:year1985lld:pubmed
pubmed-article:2411116pubmed:articleTitle[Concentration level of latamoxef sodium (LMOX) in prostatic tissue].lld:pubmed
pubmed-article:2411116pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2411116pubmed:publicationTypeEnglish Abstractlld:pubmed